The forecast for cervix uteri cancer screening coverage in Norway from 2024 to 2028 shows a slight, steady decline from 73.9% in 2024 to 73.4% in 2028. The coverage rate in 2023 stood at 74%. The year-on-year variation reveals minimal changes, with a -0.27% decrease in 2024, continuing with a -0.14% decrease annually until 2028. Over the last two years, the trend holds a decreasing pattern. The compound annual growth rate (CAGR) over the last five years indicates an average annual decline of -0.16%.
Future trends to watch for include advancements in screening technologies, policy changes in public health strategies, and potential increases in public awareness campaigns that could influence participation rates. Monitoring these factors will be crucial in understanding any shifts in the forecasted decline.